Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Young David
Pres. Research & Development at Processa Pharmaceuticals. Filing since 23 Jun 2021.
CIK 0001378166
Company
Date
Role
Action
Shares
Amount
Of holding
PCSA
Processa Pharmaceuticals, Inc.
30 Jun 2026
Pres. Research & Development
Bought
2,531
$4.88K
13.2%
PCSA
Processa Pharmaceuticals, Inc.
15 Jun 2026
Pres. Research & Development
Bought
2,067
$4.59K
12.1%
PCSA
Processa Pharmaceuticals, Inc.
29 May 2026
Pres. Research & Development
Bought
1,786
$4.59K
11.6%
PCSA
Processa Pharmaceuticals, Inc.
15 May 2026
Pres. Research & Development
Bought
1,545
$4.59K
11.2%
PCSA
Processa Pharmaceuticals, Inc.
30 Apr 2026
Pres. Research & Development
Bought
1,706
$4.59K
14.1%
PCSA
Processa Pharmaceuticals, Inc.
15 Apr 2026
Pres. Research & Development
Bought
1,545
$4.59K
14.6%
PCSA
Processa Pharmaceuticals, Inc.
31 Mar 2026
Pres. Research & Development
Bought
1,810
$4.59K
20.7%
PCSA
Processa Pharmaceuticals, Inc.
27 Jan 2025
Pres. Research & Development
Bought
124,500
$99.29K
154%
PCSA
Processa Pharmaceuticals, Inc.
7 Feb 2024
Pres. Research & Development
Bought
21,000
$51.53K
36.0%
PCSA
Processa Pharmaceuticals, Inc.
6 Feb 2024
Pres. Research & Development
Bought
20,000
$50.50K
52.1%
PCSA
Processa Pharmaceuticals, Inc.
12 Jun 2023
President & CEO
Bought
40,000
$32.00K
9.3%
PCSA
Processa Pharmaceuticals, Inc.
14 Apr 2023
President & CEO
Bought
20,000
$11.00K
4.9%
PCSA
Processa Pharmaceuticals, Inc.
13 Apr 2023
President & CEO
Bought
20,000
$9.60K
5.1%
PCSA
Processa Pharmaceuticals, Inc.
12 Apr 2023
President & CEO
Bought
20,000
$9.00K
5.4%
PCSA
Processa Pharmaceuticals, Inc.
11 Apr 2023
President & CEO
Bought
20,000
$10.40K
5.7%
PCSA
Processa Pharmaceuticals, Inc.
23 Jun 2021
Chief Executive Officer
Bought
10,000
$76.72K
3.0%
16 decisions on file.
